Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
107.92
+0.52 (+0.48%)
Official Closing Price
Updated: 7:00 PM EST, Jan 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,907,092
Open
107.50
Bid (Size)
107.10 (100)
Ask (Size)
107.95 (100)
Prev. Close
107.40
Today's Range
106.84 - 108.35
52wk Range
73.31 - 112.90
Shares Outstanding
2,531,374,696
Dividend Yield
3.15%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Merck Announces Second-Quarter 2026 Dividend
Today 15:07 EST
From
Merck & Co., Inc.
Via
Business Wire
2 Pharmaceutical Stocks Set to Rebound in 2026
↗
Today 10:37 EST
There might be massive upside ahead for these drugmakers.
Via
The Motley Fool
Performance
YTD
+1.4%
+1.4%
1 Month
+1.2%
+1.2%
3 Month
+22.6%
+22.6%
6 Month
+28.4%
+28.4%
1 Year
+10.2%
+10.2%
More News
Read More
Why Revolution Medicines Stock Plummeted by Almost 17% Today
↗
January 26, 2026
Via
The Motley Fool
The Post-Keytruda Pivot: Inside Merck’s Strategic Evolution and the RVMD Landscape
January 26, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Merck & Co. Inc. (NYSE:MRK) Stands Out as a High-Quality Dividend Stock
↗
January 24, 2026
Via
Chartmill
The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
January 26, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Revolution Medicines Stock Sinks After Merck Deal Talks Collapse
↗
January 26, 2026
Via
Benzinga
Nasdaq, S&P 500 Futures Open The Week On Edge As Earnings, Tariffs, Fed Decision Loom: Why META, NVDA, RVMD, USAR Are On Traders' Radar Today
↗
January 26, 2026
Via
Stocktwits
Topics
Economy
Stocks
Revolution Medicines Stock Stares At Big Dip After Merck Reportedly Shelves Buyout — But Analyst Flags Opportunity
↗
January 26, 2026
Via
Stocktwits
MRNA Vs NVAX: Which Vaccine Stock Is Wall Street More Bullish On Right Now?
↗
January 21, 2026
Via
Stocktwits
2 Under-the-Radar Biotech Stocks Set to Boom in 2026
↗
January 24, 2026
Via
The Motley Fool
Topics
ETFs
Intellectual Property
World Trade
2 Dirt Cheap Stocks to Buy With $200 Right Now
↗
January 24, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?
↗
January 23, 2026
Via
The Motley Fool
2 Soaring Stocks to Hold for the Next 20 Years
↗
January 23, 2026
Via
The Motley Fool
Topics
Intellectual Property
World Trade
Stability Meets Scale: Why Johnson & Johnson is Poised for a Breakout 2026
January 23, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Economy
I Correctly Predicted That These 15 Dow Jones Stocks Would Boost Their Payouts in 2025. Here's Why It Can Happen Again in 2026.
↗
January 22, 2026
Via
The Motley Fool
Topics
Stocks
Moderna and Merck Solidify Oncology Leadership as Five-Year Melanoma Data Fuels Market Rally
January 22, 2026
Via
MarketMinute
Topics
Intellectual Property
Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth
January 22, 2026
Via
MarketMinute
Topics
Earnings
Economy
Intellectual Property
Moderna’s 2026 Pivot: From Pandemic Pioneer to Oncology Powerhouse
January 22, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm
January 21, 2026
Via
StockStory
Topics
Economy
Stocks
Why Moderna Stock Surged Today
↗
January 21, 2026
Via
The Motley Fool
Merck Shares Rise On $30M Funding From CEPI To Develop Affordable Ebola Vaccine
↗
January 21, 2026
Via
Stocktwits
Topics
Workforce
Moderna Stock Still Worth 37% Less After Cancer Vaccine Data? BofA’s New Price Target Keeps Retail Traders Cautious
↗
January 20, 2026
Via
Stocktwits
Moderna Shares Rise On Five-Year Follow-Up Takeaways For Skin Cancer Vaccine: Retail Applauds ‘Solid’ Update
↗
January 20, 2026
Via
Stocktwits
GSK Challenges Xolair Dominance with $2.2 Billion Acquisition of RAPT Therapeutics
January 20, 2026
Via
MarketMinute
Topics
Intellectual Property
Frequently Asked Questions
Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 107.92
When was Merck & Co last traded?
The last trade of Merck & Co was at 01/27/26 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 273.19B
How many shares of Merck & Co are outstanding?
Merck & Co has 273B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.